Figure 1.

Kaplan-Meier curves for frailty-free survival: (A) HIV(−) men by ATP-III FRS risk; (B) HIV(+) men by ATP-III FRS risk; (C) HIV(−) men by ACC/AHA PCE risk; (D) HIV(+) men by ACC/AHA PCE risk. For ATP-III FRS, individuals with >20% estimated risk of CHD within 10 years are high risk; persons with 10–20% risk are moderate risk, and persons with <10% risk are low risk. Individuals with ACC/AHA PCE ≥7.5% have high 10-year risk of ASCVD while those with ACC/AHA PCE <7.5% have low 10-year risk of ASCVD